CAS RN: 885273-56-3
(3-O-TOLYL-ISOXAZOL-5-YL)-METHANOL
Product Availability
Choose a grade to view its available package options.
4 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250528 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20250316 |
100mg / 250mg / 1g |
Out of stock |
8-10 business days | Inquiry |
| Batchno.20251011 |
1g |
Out of stock |
| Inquiry |
| Batchno.20250830 |
250mg |
Out of stock |
| Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 1g, 5g, 0.25g
- Available purity: ≥95%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 885273-56-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
5
In Stock
|
Beijing |
Inquiry |
| 1g |
≥95% |
5
In Stock
|
Hong Kong |
Inquiry |
| 5g |
≥95% |
5
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
≥95% |
2
In Stock
|
Shenzhen |
Inquiry |
885273-56-3 / [3-(2-methylphenyl)-1,2-oxazol-5-yl]methanol
Standard CAS: 885273-56-3
Multi CAS: No
Basic Information
CAS
885273-56-3
Multi CAS
No
Molecular Formula
C11H11NO2
Molecular Weight
189.210000
Exact Mass
189.078979
InChI
InChI=1S/C11H11NO2/c1-8-4-2-3-5-10(8)11-6-9(7-13)14-12-11/h2-6,13H,7H2,1H3
InChIKey
BQNUCDAEKSZWEE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
14
Aromatic heavy atom count
11
Fraction Csp3
0.18
Rotatable bonds
2
H-bond acceptors
3
H-bond donors
1
Molar refractivity
52.6
TPSA
46.26
LogP / Solubility
WLOGP
2.14
MLOGP
1.88
XLogP3
1.5
Consensus LogP
1.84
Log S (ESOL)
-2.81
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.66
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.91
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.35
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5